Target intelligence / Profile preview

Adenovirus early region 1B 55kDa protein (E1B-55K)

Target
E1B-55K
Molecular classification
Viral protein, E3 ubiquitin ligase component, Transcription regulator, RNA-binding protein
01

Overview

The Adenovirus early region 1B 55kDa (E1B-55K) protein is a multifunctional viral regulatory protein essential for efficient adenovirus replication and host cell transformation (UniProt P03243). Its primary biological function involves the neutralization of the host's innate antiviral responses, most notably through the direct binding and inactivation of the tumor suppressor protein p53 (PubMed: 10591211). By inhibiting p53-mediated apoptosis and cell cycle arrest, E1B-55K ensures the survival of the infected cell during the viral production phase. Furthermore, E1B-55K works in conjunction with the viral E4orf6 protein to form an E3 ubiquitin ligase complex that targets various host proteins, such as Mre11 and DNA ligase IV, for degradation (PubMed: 15542591). This complex also facilitates the selective transport of viral late mRNAs from the nucleus to the cytoplasm. In oncology, E1B-55K is a pivotal target for the design of oncolytic viruses, such as ONYX-015 and H101 (Oncorine). These therapeutic agents are engineered with a deletion in the E1B-55K gene, theoretically restricting their replication to p53-deficient cancer cells while sparing normal cells where functional p53 can restrict viral growth (Wikipedia: ONYX-015).

Other names
E1B-55KAdenovirus type 5 E1B 55kDa proteinEarly adaptive protein E1B 55kDap53-associated protein
02

Mechanism of action

Selective oncolytic viral replication in p53-deficient cells achieved through the deletion of the E1B-55K gene, which prevents the virus from neutralizing p53 in normal cells.

03

Biological functions

Inhibition of p53-mediated apoptosisNucleocytoplasmic mRNA transportProteasomal degradation of host proteinsViral genome replicationCell cycle modulation
04

Disease associations

Adenovirus infectionCancer
05

Safety considerations

HepatotoxicityImmune response to viral capsidPotential for recombination with wild-type adenovirusOff-target replication in cells with impaired p53 pathways
06

Interacting drugs

ONYX-015

1 more in the full profile.

07

Biomarkers

TP53 mutation statusp53 protein expression levels

Beyond the preview

Go deeper on Adenovirus early region 1B 55kDa protein (E1B-55K).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenovirus early region 1B 55kDa protein (E1B-55K).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call